Editorial: Comorbidities, Concomitant Medications, and Potential Drug-Drug Interactions With Interferon-Free Direct-Acting Anti-Viral Agents in Chronic Hepatitis C

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15051
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Comorbidities, Concomitant Medications and Potential Drug-Drug Interactions With Interferon-Free Direct-Acting Anti-Viral Agents in Chronic Hepatitis C - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Contraindicated Drug-Drug Interactions Before and After Initiation of Direct-Acting Anti-Viral Agents in Chronic Hepatitis C Patients in Taiwan

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Contraindicated Drug-Drug Interactions Before and After Initiation of Direct-Acting Anti-Viral Agents in Chronic Hepatitis C Patients in Taiwan. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Correction: Real-Life Data on Potential Drug-Drug Interactions in Patients With Chronic Hepatitis C Viral Infection Undergoing Antiviral Therapy With Interferon-Free DAAs in the PITER Cohort Study

PLoS ONE
Multidisciplinary
2018English

Letter: Hepatitis B Virus Reactivation in Patients With Chronic Hepatitis C During Direct-Acting Anti-Viral Therapy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Cost Effectiveness of Hepatitis C Positive Donor Kidney Transplantation for Hepatitis C Negative Recipients With Concomitant Direct-Acting Anti-Viral Therapy

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2018English

The Majority of Hepatitis C Patients Treated With Direct Acting Antivirals Are at Risk for Relevant Drug-Drug Interactions

United European Gastroenterology Journal
OncologyGastroenterology
2016English

Generic Sofosbuvir-Based Interferon-Free Direct Acting Antiviral Agents for Patients With Chronic Hepatitis C Virus Infection: A Real-World Multicenter Observational Study

Scientific Reports
Multidisciplinary
2018English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy